News Releases
Pharmaceuticals
Most Read
- May 15, 2013, 09:23 ET Sylvia Day's Entwined With You, Crossfire Book 3, is On-Sale Worldwide on June 4, 2013
- Feb 04, 2013, 11:23 ET Top 100 College Party Schools of 2013
- May 15, 2013, 14:39 ET Mineral Detox, a Product that May Be a Herpes Cure to Resolve Herpes, is Available through New Site
Most Emailed
- May 13, 2013, 08:00 ET STERIPLEX SD® Fights C. diff And Life-threatening Superbugs With Powerful Combination Of Safety And Efficacy
- May 16, 2013, 13:35 ET Sonendo® Debuts New Endodontic Multisonic Ultracleaning™ System at AAE 2013 Hawaii
- May 16, 2013, 14:00 ET Coors Banquet Designates Best Banquet Bars in America
Organizations in the News
The organizations with the most activity in PR Newswire's News Room
American Registry Zacks Investment Research, Inc. Marcum LLPJournalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Download our 2013 SEC Filing Calendar
Our 2013 SEC Calendar includes all required SEC filings deadlines and holiday closures
New! View News by location
- < Prev
1
- Next >
-
May 21, 2013, 18:22 ET
NABP's .PHARMACY Proposal Passes Initial ICANN Evaluation
Reaching a critical milestone in the generic Top-Level Domain (gTLD) approval process, the National Association of Boards of Pharmacy®... -
May 21, 2013, 17:00 ET
Valeant Pharmaceuticals Announces 2013 Annual Meeting Results
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced the election of ten directors nominated at its 2013 annual... -
May 21, 2013, 16:30 ET
European Medicines Agency (EMA) Accepts Veloxis' Marketing Authorization Application (MAA) for LCP-Tacro for Treatment of Kidney Transplant Patients
Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that the European Medicines Agency (EMA) accepted for review the company's Marketing... -
May 21, 2013, 16:05 ET
Regulus to Present at Deutsche Bank 38th Annual Healthcare Conference
Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting... -
May 21, 2013, 14:41 ET
RenovoRx Named Winner of 2013 TiE50 "Top Startup"
RenovoRx (www.renovorx.com) has been named Winner of the prestigious 2013 TiE50 "Top Startup" Award at TiEcon 2013, the world's largest annual... -
May 21, 2013, 14:16 ET
National Association of Specialty Pharmacy™ (NASP™) Announces Strategic Business Exchange Event in October 2013
The National Association of Specialty Pharmacy™ (NASP™) announced today it will host its 2013 Fall Strategic Business Exchange meeting... -
May 21, 2013, 13:09 ET
First Aid Shot Therapy®, Inc. ("F.A.S.T.") Completes Series A Financing Round
First Aid Shot Therapy®, Inc. ("F.A.S.T."), a consumer healthcare company focused on over-the-counter (OTC) therapies in liquid 'shot' (40ml... -
May 21, 2013, 12:50 ET
Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia
On its tenth anniversary Pi2 introduced its new corporate image and impressive new product developments at the Special Libraries Association PHTD... -
May 21, 2013, 11:55 ET
Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer
Kepner-Tregoe (KT), the global capability development and consulting company, today announced that 13-year veteran Chris Geraghty has been... -
May 21, 2013, 10:31 ET
Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show
The 2013 Pharma ChemOutsourcing Show slated for Sept 17-19 in NJ has attracted the greatest number of "Emerging" small molecule biotech... -
May 21, 2013, 09:37 ET
Armada Announces New Corporate Website to Showcase Expanded Services to Specialty Pharmacy Marketplace
Armada Health Care (Armada) is pleased to announce the launch of the new Armada corporate website (www.armadahealthcare.com). This new... -
May 21, 2013, 09:30 ET
Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the effect of... -
May 21, 2013, 09:30 ET
The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the... -
May 21, 2013, 09:00 ET
Avion Pharmaceuticals, LLC., launches Prenate Chewable™, the newest addition to the Prenate® Prenatal Vitamin Family
Avion Pharmaceuticals, a specialty pharmaceutical company, recently announced the launch of Prenate Chewable™, a chewable,... -
May 21, 2013, 09:00 ET
Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors
Hurel Corporation ("Hurel"), a world-leading provider of advanced artificial tissue constructs and microfluidic cell-based assay platforms, today... -
May 21, 2013, 08:30 ET
New Data Validates CyberKnife SBRT for Prostate Cancer Treatment
Accuray Incorporated (Nasdaq: ARAY), announced today the publication of study results involving hundreds of prostate cancer patients treated... -
May 21, 2013, 08:15 ET
Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients
Janssen R&D Ireland (Janssen) today announced primary efficacy and safety results from the global Phase 3 PROMISE study demonstrating that... -
May 21, 2013, 08:15 ET
Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine
Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the New England Journal of Medicine... -
May 21, 2013, 08:03 ET
Diclegis® Now Available Nationwide To Treat Pregnant Women With Nausea And Vomiting Of Pregnancy (NVP)
Duchesnay USA, the first pharmaceutical company dedicated to the health of pregnant women, announces the U.S. market introduction of... -
May 21, 2013, 08:00 ET
BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference
BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC BB: BRTX), a life sciences company focused on developing stem cell based...
- < Prev
1
- Next >
